In Vivo Pharmacodynamic Characterization of T-705 in an Experimental Influenza Infection Model in Mice

被引：0
作者：
Takahashi, K. [1 ]
Kadota, T. [1 ]
Tanaka, T. [1 ]
Komeno, T. [1 ]
Hayakawa, H. [1 ]
Mitsuyama, J. [1 ]
Furuta, Y. [2 ]
Shiraki, K. [3 ]
机构：
[1] Toyama Chem Co LTD, Res Labs, Toyama, Japan
[2] Toyama Chem Co LTD, Business Dev Dept, Tokyo, Japan
[3] Toyama Univ, Dept Virol, Toyama 930, Japan
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.425
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E170 / E171
页数：2
相关论文
共 50 条
  • [41] Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
    Smee, Donald F.
    Hurst, Brett L.
    Egawa, Hiroyuki
    Takahashi, Kazumi
    Kadota, Takumi
    Furuta, Yousuke
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (04) : 741 - 746
  • [42] EXPERIMENTAL SLOW INFLUENZA INFECTION IN MICE
    ZUEV, VA
    MIRCHINK, EP
    KHARITONOVA, AM
    VOPROSY VIRUSOLOGII, 1983, (01) : 24 - 29
  • [43] In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Valnemulin in an Experimental Intratracheal Mycoplasma gallisepticum Infection Model
    Xiao, Xia
    Sun, Jian
    Yang, Tao
    Fang, Xi
    Wu, Dong
    Xiong, Yan Q.
    Cheng, Jie
    Chen, Yi
    Shi, Wei
    Liu, Ya-Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 3754 - 3760
  • [44] Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors
    Huchting, Johanna
    Vanderlinden, Evelien
    Winkler, Matthias
    Nasser, Hiba
    Naesens, Lieve
    Meier, Chris
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) : 6193 - 6210
  • [45] Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice
    Hawman, David W.
    Haddock, Elaine
    Meade-White, Kimberly
    Williamson, Brandi
    Hanley, Patrick W.
    Rosenke, Kyle
    Komeno, Takashi
    Furuta, Yousuke
    Gowen, Brian B.
    Feldmann, Heinz
    ANTIVIRAL RESEARCH, 2018, 157 : 18 - 26
  • [46] Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
    Oestereich, Lisa
    Rieger, Toni
    Neumann, Melanie
    Bernreuther, Christian
    Lehmann, Maria
    Krasemann, Susanne
    Wurr, Stephanie
    Emmerich, Petra
    de Lamballerie, Xavier
    Oelschlaeger, Stephan
    Guenther, Stephan
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (05):
  • [47] The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
    Jin, Zhinan
    Smith, Lucas K.
    Rajwanshi, Vivek K.
    Kim, Baek
    Deval, Jerome
    PLOS ONE, 2013, 8 (07):
  • [48] Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
    Mendenhall, Michelle
    Russell, Andrew
    Smee, Donald F.
    Hall, Jeffery O.
    Skirpstunas, Ramona
    Furuta, Yousuke
    Gowen, Brian B.
    PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (10)
  • [49] In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model
    Andes, D.
    Craig, W.
    Nielsen, L. A.
    Kristensen, H. H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 3003 - 3009
  • [50] In Vivo Imaging of Influenza Virus Infection in Immunized Mice
    Czako, Rita
    Vogel, Leatrice
    Lamirande, Elaine W.
    Bock, Kevin W.
    Moore, Ian N.
    Ellebedy, Ali H.
    Ahmed, Rafi
    Mehle, Andrew
    Subbarao, Kanta
    MBIO, 2017, 8 (03):
12345